A questionnaire indicating the presence of a history or physical findings consistent with liver disease or bleeding disorders was completed by house officers on 301 admissions to a Veterans Administration medical service. 
In a survey of four medical services at Veterans Administration Hospitals in different regions of this country, we found that 78% of unpatients had their prothrombin times measured on admissiod. House officers and attending staff generally believed that the test was of use in detecting occult liver disease or coagulation disorders, despite the absence of data to support this belief.
Therefore, we have studied the usefulness of the prothrombun time in screening for occult, asymptomatie liver disease or coagulation disorders in a population of patients admitted to the medical service of a university-affiliated VA Hospital. Our results show the prothrombun time to have no advantages over a careful history and physical examination in screening for liver disease and coagulation defects. Furthermore, we believe that the analysis of these data provides a model for the evaluation of the clinical utility of other routine laboratory tests.
Methods
We requested that house officers determine the prothrombin.time and other liver function tests (serum aspartate aminotransferase, bilirubin, albumin, alkaline phosphatase, and lactate dehydrogenase) on each patient admitted to the University of Pennhylvariia medical service at the Philadelphia VA Hosital during two months. Before the results of laboratorj tests were known, the house officers completed a simple questionnaire designed to indicate the presence of a case history or physical findings pertinent for liver disease or coagulation disorders. Prothrombin time was already routinely being measured for 78.6% of the admitted patients before we began this study, so its measurement as a routine procedure did not diverge from accepted practice. Of 423 consecutive admissions, the questionnaire was completed and the prothrombin time was measured for 301 (71.2%).
Data provided by the questionnaire included: (a) whether the house officer obtained a history that indicated that the patient abused alcohol; (b) whether the patient had a history that the house officer identified as being associated with liver disease (e.g., increasing abdominal girth, darkened urine, previously documented liver disease); (c) whether the patient had a history compatible with ease of bleeding (e.g., anticoagulation therapy, gross blood loss, easy bruising); and (d) whether the patient had findings on physical examination that the house officer identified as being indicative of liver disease (e.g., spider angiomata, hepatomegaly, jaundice) or physical findings associated with abnormal bleeding tendency (e.g., purpura, petechiae).
On the day after a patient's admission, one of the investigators collected the completed questionnaires and recorded the results of the prothrombin time measurement and liver function tests. An abnormal prothrombin time was defined as one in which the patient's time to coagulation was 2 or more seconds longer than control. These data were coded and entered onto IBM Hollerith computer cards and analyzed.
Results
Of the entire sample of 301 patients with both a prothrombin time performed and questionnaire completed, 44 (14.6%) had abnormal values. The sample population was divided into four groups for analysis. These groups and the results of prothrombin time testing are displayed in Table 1 .
Group I: Negative History and Physical Examination
Of the 301 patients, 107 (35.6%) had neither a history nor physical examination indicative of liver disease or ease of bleeding and were not considered by the house officers to abuse alcohol. Only two of these patients (1.9%) had an abnormal prolonged prothrombin time, and one of these was ascribed to laboratory error, because it was found to be within normal limits when the test was repeated. For the other patient in this group with an abnormal prothrombin time, the result was never repeated and was never mentioned in the clinical record. Therefore, in the asymptomatic patient with no physical findings of liver disease or bleeding, the prothrombin time did not add any additional useful information to the history and physical examination.
Group II: Positive History, Negative

Physical Examination
Another 112 patients (37.2%) had a history that was associated with liver disease or coagulation abnormalities but had no pertinent findings on physical examination. Thirteen patients (11.6%) of the 112 had an abnormal prothrombin time.
Group Ill: Positive History and Physical Examination
The third group of patients had both a pertinent history and a pertinent physical examination.
A "pertinent" physical examination included stigmata of liver disease or evidence of bleeding. Of the 301 patients studied, 73 fell into this category (24.2%). In this group 25 of the 73 patients (34.2%) had a prolonged prothrombin time on admission.
Group IV: Negative History and
Positive Physical Examination
The remaining nine patients (3.0%) had a pertinent physical examination but denied any pertinent historical information.
Four of these patients (44.4%) had an abnormal prothrombin time.
Further Subdivision of Subjects
We next sought to determine whether further division of these groups would provide useful information. Therefore, we subdivided groups II and III according to type of history presented.
Alcoholism.
For group II, the patients with a pertinent history and negative physical examination, the subdivisiOn by type of history is shown in Table 2 . For 73 of these patients, the history was that of alcoholism without a known history of liver disease. Only one of these alcohol abusers (1.4%) had an abnormal prothrombin time. He was treated with oral vitamin K; prothrombin time was not later re-measured, and he was discharged without follow-up arrangements. Therefore, for none of these chronic alcoholics did determination of the prothrombin time result in any change in long-term management.
History of liver disease. Another 15 of the patients with a positive history but negative physical examination (13.4%) had a past history of known liver disease. Two of these patients (13.3%) had a prolonged prothrombin time. There were 13 patients (11.6%) who were taking oral anticoagulants at the time of admission, of whom 8 (6 1.5%) had a prolonged prothrombin time. Another 11 patients (9.8%) without pertinent findings on physical examination gave a history indicative of a clinical situation associated with an abnormal bleeding tendency. Two of these 11 patients (18.2%) had a prolonged prothrombin time. Type of history. Likewise, group III, which included the patients with a pertinent history and a positive physical examination, was subdivided by the type of history presented (Table 2 ). Of 26 patients whose history was that of alcoholism alone with no history specific for liver disease, only 3 (11.5%) had an abnormal prothrombin time. However, for 41 patients (56.2%) the history was one indicative of liver disease. In this group 19 (46.3%) had a prolonged prothrombin time. Three patients on anticoagulants (4.1%) also had pertinent physical findings. Each had an abnormal prothrombin time. Three other patients with pertinent physical examinations gave histories of bleeding. Each had a normal prothrombin time. In none of these subgroups of group III would we choose to forego routine prothrombin time testing on admission.
Chi-square analysis showed these differences in the frequency of abnormal prothrombin times between the subgroups within groups II and III to be highly significant (P <0.0001).
We also compared the prothrombin time and other liver function tests. When patients on anticoagulants are excluded, only two of the 44 patients with an abnormal prothrombin time had completely normal liver function tests. One of these two patients had an abnormal prothrombin time that was not repeated and was never entered into the clinical record. The other was a patient who presented with gastrointestinal bleeding and a hemoglobin of 48 g/liter. Prolonged prothrombin time in anemic patients has been recognized as a potential artifact, caused either by increased plasma volume and dilution of coagulation factors or by consumption of the factors (7). In neither case was the prothrombin time of use in detecting occult disease and thereby prompting a change in patient management.
DiscussIon
The one-stage prothrombin time reflects the presence or functional absence of those factors involved in the extrinsic clotting system (I, II, V, VII, X) and is therefore a measure of hepatic synthetic function (2, 3) . Although Deutsch (3) and Wurzel (4) found at least one abnormal clotting study in over 85% of patients with liver disease, the prothrombin time can be normal despite significant liver disease (2) . A normal prothrombin time may be obtained with factor values as low as 25 to 30% of normal. In Deutsch's study (3) , only 58 of 192 patients (30.2%) with known liver disease had an abnormal prothrombin time. When the ability of the prothrombin time to detect liver disease is compared with that of other liver function tests, it is found to be inferior, having a larger number of normal results and adding little to the other tests in terms of disease detection (3, 5, 6) .
While the prothrombin time has been extensively studied in patients known to have liver disease, its role as a screening test for occult liver disease and coagulation disorders had not been previously studied. One would expect that such a test, which requires severe disease in order to produce an abnormal result, would detect occult disease infrequently;
but a large amount of reliance seems to have been placed on the test despite the absence of substantiation of its effectiveness. In this prospective study we have shown that 44 of 301 patients at a VA Hospital had abnormal prothrombin times on admission. Characterization of the patients by history and physical examination identifies certain groups to be most likely to have prolonged prothrombin times. For two types of patients, the yield from routine prothrombin times was exceedingly low: first, in 107 patients with no pertinent history or physical examination (Group I); second, in 73 patients with a history of alcohol abuse but no history of liver disease or ease of bleeding and no pertinent findings on physical examination (a subgroup of Group II). In these 180 of 301 patients (59.9%), only three had an abnormal prothrombin time. In none was the test of clinical significance. Of the remaining 121 patients (40.1%), who had a pertinent history or physical examination or both, 41 had a prolonged prothrombin time. The prothrombin time was abnormal in only two patients who had normal liver function studies, and it did not serve as a useful routine screening test in either patient.
Therefore, the physician could draw blood for a prothrombin-time test from a selected 40% of all admitted patients and miss no clinically useful prothrombin times; that is, the test would not be ordered for patients with a negative history and physical examination or for those whose pertinent history is only that of alcoholism.
Because we chose to conduct this study at a Veterans Administration Hospital, with a higher than usual frequency of liver disease among its patients, the usefulness of the routine screening prothrombin time in the general hospital population may actually be even less than we have calculated.
It should also be recognized that these conclusions cannot be extrapolated to a surgical service, where missing a clotting abnormality in a pre-operative patient, albeit rare, could be catastrophic.
In conclusion, we have found the prothrombin time to have very limited value in the absence of a pertinent history Or a physical examination indicative of liver disease or a coagulation abnormality and, therefore, recommend that it not be used as a routine admission test in medical patients. Instead, the prothrombin time should be reserved for patients with specific clinical evidence of liver disease, anticoagulation, or other conditions predisposing to bleeding disorders.
